Cell death in T- and B-cell development.
Debatin
K M
KM
Dept. Pediatrics, University of Ulm, Germany. klaus-michael.debatin@medizin.uni-ulm.de
D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D001327:Autoimmune Diseases / Q000473:pathology; D001402:B-Lymphocytes / Q000166:cytology* / Q000187:drug effects; D020169:Caspases / Q000502:physiology; D053938:DNA Fragmentation; D053222:Fas Ligand Protein; D006801:Humans; D007165:Immunosuppression Therapy; D008232:Lymphoproliferative Disorders / Q000473:pathology; D008562:Membrane Glycoproteins / Q000502:physiology; D008928:Mitochondria / Q000502:physiology; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000166:cytology* / Q000187:drug effects; D019014:fas Receptor / Q000502:physiology
D000970:Antineoplastic Agents; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D018124:Receptors, Tumor Necrosis Factor; D019014:fas Receptor; D020169:Caspases